Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils.
about
Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalizationCathelicidin impact on inflammatory cellsAntiviral potential of cathelicidinsRoles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseasesAntiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.Generation of novel bone forming cells (monoosteophils) from the cathelicidin-derived peptide LL-37 treated monocytes.Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities.LL-37 modulates human neutrophil responses to influenza A virus.SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humansCathelin-related antimicrobial peptide differentially regulates T- and B-cell function.Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural AnalysisCathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions.Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activityThe Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected WoundsNeutrophil-derived cathelicidin promotes adhesion of classical monocytes.Identification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin αMβ2 (Mac-1, CD11b/CD18) that Promotes Phagocytosis by Opsonizing Bacteria.LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells.Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.Neutrophil-derived cathelicidin protects from neointimal hyperplasia.The role of natural antimicrobial peptides during infection and chronic inflammation.Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense.Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis.Thrombin-derived host defence peptide modulates neutrophil rolling and migration in vitro and functional response in vivo.The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils.Anti-bacterial factors secreted from cumulus cells of ovulated COCs enhance sperm capacitation during in vitro fertilization.Spotlight on Human LL-37, an Immunomodulatory Peptide with Promising Cell-Penetrating Properties.Alarmins and immunity.The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthma.Cathelicidin LL-37 Affects Surface and Intracellular Toll-Like Receptor Expression in Tissue Mast Cells.Cathelicidin rCRAMP stimulates rat mast cells to generate cysteinyl leukotrienes, synthesize TNF and migrate: involvement of PLC/A2, PI3K and MAPK signaling pathways.
P2860
Q24296488-350E6AA8-8810-4C08-A3B3-682E16ECE483Q26777983-D2AB4A74-0E30-4646-A36C-AF1B1B966324Q27006576-C829C1EF-A3D0-430A-AA27-24DD499EC2ABQ28079028-4561427E-CBC5-4D26-85DC-483EC5EF4DAEQ28477585-616F78E9-1995-4970-A7D2-EB8EFF43E42CQ33700171-1458ADF2-766B-4B0F-9BEF-AEA648A1D702Q33749859-EC464B07-AFA2-44F3-A710-4CB3009556B3Q34035658-10FE3E80-2E5B-45DA-B509-5468ED25C3B5Q34341371-7708CAC4-FD29-434F-AC18-1141367F0F11Q35183636-B2DDF875-3031-4AC9-8B04-9603E40AB822Q35602632-0134EDE9-7293-4C8D-8DE6-6893E341520EQ35609334-B706272E-17C8-46FF-A798-09D95F9B30E6Q35755845-EAB683BF-B89A-4375-8943-1EA65D301137Q36298336-AC8FCE3B-2BB6-424B-8E18-EB697D8F2282Q36481842-A5156167-930F-46BA-9978-8D5348C7666BQ36977156-10417348-7073-4EDF-918B-15D9BEFE93F8Q36984720-880F307A-3EF5-4DB5-B92A-754FE40E5F62Q37505380-6E73C62F-81D4-4FB4-AA99-AE8F3260B2B9Q37547116-AA24D517-46B6-496A-8AF9-A7540C9121C0Q38162670-F9A8C75A-BBA7-4A82-B6BF-46ABD77746ECQ40000791-054AF260-1DA1-4E05-B0EC-64F06D16EB38Q40063866-2B441C85-5F31-4FFF-A0FA-B22432BD3687Q40091655-CDA8EE1D-1B61-4850-9FD4-5FFEF564DF41Q40367916-7F94EC38-3F50-4626-858C-1147C1693A0BQ41322040-BB47E632-BA0B-4371-BB35-1E1CA561EA2AQ42149510-76484D87-3B99-42A8-9D6D-8071533FBA61Q43450100-39D008C8-B254-4149-9004-B70547529D6DQ46697816-11C59884-A791-40CC-A3FA-499B6D30A191Q48193695-83169046-CF78-4C82-92B5-BB234B7EF675Q53123996-720FFE45-6570-4140-B18C-33B972C16EA9Q55010741-8E9AF2C6-2581-430A-A6E8-5EB269DD17B1Q55073342-B0C15C2E-41EF-4AA5-BBA1-8D3E5A6D818A
P2860
Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@ast
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@en
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@nl
type
label
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@ast
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@en
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@nl
prefLabel
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@ast
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@en
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@nl
P2093
P2860
P356
P1476
Evidence that cathelicidin pep ...... or CXCR2 on human neutrophils.
@en
P2093
David M Rose
Frances Chang
Gregory Cherryholmes
Ingrid Schraufstatter
John E Shively
Zhifang Zhang
P2860
P304
P356
10.1002/EJI.200939496
P407
P577
2009-11-01T00:00:00Z